Bausch + Lomb outlines Vision '27 strategy while maintaining 2025 revenue guidance at $5.05B–$5.15B

Discover Bausch + Lomb's Q3 2025 earnings highlights: strong revenue growth, Vision '27 strategy, and upcoming innovation pipeline.

7 Analysts Have This To Say About Bausch & Lomb

Analysts have set 12-month price targets for Bausch & Lomb, revealing an average target of $17.0, a high estimate of $19.00, ...
Standard-Journal

Bausch + Lomb Announces Third-Quarter 2025 Results

Bausch + Lomb Corporation (NYSE/TSX: BLCO), a leading global eye health company dedicated to helping people see better to live better, today announced its third-quarter 2025 financial results.
MarketWatch

Bausch + Lomb Raises Outlook as 2Q Revenue Rises, Loss Narrows

Bausch + Lomb raised its full-year revenue expectation after reporting a narrowed second-quarter loss and higher revenue. The eye-health company on Wednesday said it now expects revenue for the full ...